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Cyclooxygenase-1 in cutaneous barrier 
repair
Scratching behaviour in 
patients with atopic der-
matitis can cause cutane-
ous barrier disruption. A 
previous study showed 
that indomethacin delayed 
recovery from the effects 
of cutaneous barrier dis-
ruption. Honma et al. 
compared the effects of SC-
560 and NS-398 on mech-
anical scratching-induced 
cutaneous barrier disrup-
tion to elucidate the role of 
cyclooxygenase (COX)-1 and COX-2 in regulatory mechanisms 
underlying barrier repair in mice. COX-1 inhibition delayed the 
cutaneous barrier repair, and COX-1-positive cells identified as 
Langerhans cells were expressed in the basal epidermal layer. 
Further, COX-1-coupled prostaglandin D2 biosynthesis may 
be an important factor in barrier repair.  Br J Dermatol 2007; 
156:1178–87.
In vivo quantification of microvessels in 
clinically uninvolved psoriatic skin and in 
normal skin
What came first, the chicken or the egg? Do abnormal 
microvessels cause psoriatic plaques or are they a consequence 
of psoriasis? Hern and Mortimer’s study indicates that prior 
to the development of clinical lesions there are no significant 
morphological differences between the dermal microvessels 
in the clinically uninvolved skin of psoriatic subjects and the 
dermal microvessels in the normal skin of healthy volunteers. 
However, during plaque formation, the superficial papillary 
microvessels in plaque skin undergo a striking, characteristic 
change, i.e. elongation, widening and tortuosity. These blood 
vessels must therefore, at least in part, play an important, neces-
sary, but probably secondary role in the pathogenesis of clini-
cal lesions in psoriasis. Br J Dermatol 2007; 156:1224–9.
Should eye protection be worn during 
dermatological surgery: prospective 
observational study
The quantification of facial contamination with blood has 
never been reported in the context of dermatological surgery. 
One hundred consecutive operations were assessed to record 
the number of blood splashes in each procedure. Thirty-three 
per cent of all surgical procedures resulted in at least one facial 
splash to the operator, with the most striking predisposing factor 
being use of the bipolar for electrocautery, with 27 of 57 (47%) 
procedures involving this instrument resulting in blood splash-
es. In an accompanying survey the majority of British Society 
for Dermatological Surgery members thought that they receive 
a blood splash in 1% or less of surgical procedures, suggest-
ing that surgeons may be inadvertently exposing themselves to 
blood contamination. Br J Dermatol 2007; 156:1252–6.
Neuropeptides and their receptors in 
psoriatic skin in relation to pruritus
Neuropeptides are well known to be responsible for the induc-
tion and maintenance of the inflammatory process of psoria-
sis. Studies have revealed a marked proliferation of cutaneous 
nerves and presence of substance P (SP), vasoactive intestinal 
peptide, calcitonin gene-related peptide (CGRP), nerve growth 
factor (NGF) and protein gene product 9.5 in psoriatic plaques. 
Of 152 psoriatic patients studied, 73.7% suffered from pruri-
tus, and these patients had a higher mean Psoriasis Area and 
Severity Index (PASI) score than psoriatic patients without pruri-
tus. There was positive correlation between the PASI score and 
the intensity of pruritus. Keratinocytes in the psoriatic plaques 
of patients with pruritus showed consistently increased expres-
sion of SP receptor (SPR), high-affinity NGF receptor (TrkA) 
and CGRP receptor (CGRPR). Pruritus is a common feature in 
psoriasis. Considering the well-known roles of neuropeptides 
in the pathogenesis of both psoriasis and pruritus, increased 
SPR, TrkA and CGRPR may be involved in the pathogenesis of 
pruritus in psoriasis and the severity of psoriasis. Br J Dermatol 
2007; 156:1266–71.
Psoriasis has a major secondary impact 
on the lives of family members and 
partners
Psoriasis can have a profound effect on a patient’s quality of 
life (QoL), and lack of understanding by family members may 
increase a patient’s level of anxiety. Until recently, there has 
been little awareness of the concept of the secondary impact 
of skin disease on a patient’s family and of its importance. 
However, the impact of childhood atopic dermatitis (AD) on 
the sufferer’s family has been investigated. In AD the qual-
ity of family life can be significantly affected, and the extent 
of this impact is related to the severity of the disease. The QoL 
of partners and relatives of people with psoriasis can also be 
significantly affected. Many different aspects of everyday life 
that are affected and the psychological impacts of having a 
partner or relative with psoriasis have been identified. It is of 
great importance to identify these issues to allow clinicians to 
develop appropriate care strategies not only for patients with 
psoriasis, but also for their partner and family.  Br J Dermatol 
2007; 156:1302–7.
